Medicine Description migriza 10mg
Migriza 10mg Tablets is a medication that belongs to the class of selective serotonin receptor agonists, specifically targeting the 5-HT1B and 5-HT1D receptors in the brain. By stimulating these receptors, Rizatriptan causes vasoconstriction of dilated intracranial blood vessels, which is a key feature of migraine pathophysiology. Furthermore, Rizatriptan modulates the release of pro-inflammatory neuropeptides such as CGRP and substance P, which contribute to the sensation of pain during a migraine attack. Through these multifaceted actions, Migriza effectively alleviates the symptoms of acute migraines.
Indications and Uses of Migriza 10mg Tablets
- Acute treatment of migraine attacks with or without aura in adults
- Management of migraine episodes in pediatric patients aged 6 to 17 years
Side Effects of Migriza 10mg Tablets
- Drowsiness or fatigue
- Dizziness or lightheadedness
- Nausea or vomiting
- Dry mouth
- Chest tightness or discomfort
Storage and Handling
Store Migriza 10mg Tablets at room temperature, away from moisture and heat. Ensure that the medication is kept out of reach of children and pets.
Patient Advice and Precautions
Patients should be advised to avoid using Migriza in conjunction with other triptans or ergotamine products to prevent additive effects. It is important to inform healthcare providers about any history of cardiovascular disease prior to use. Additionally, patients should be counseled on recognizing signs of serious side effects such as chest pain or severe dizziness, which require immediate medical attention.